Home/Filings/4/0001140361-17-008434
4//SEC Filing

CASTLIGHT HEALTH, INC. 4

Accession 0001140361-17-008434

CIK 0001433714operating

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 8:17 PM ET

Size

16.0 KB

Accession

0001140361-17-008434

Insider Transaction Report

Form 4
Period: 2017-02-16
McCracken John
SVP, World Wide Sales
Transactions
  • Exercise/Conversion

    Class B Common Stock

    2017-02-16+31,25031,250 total
  • Exercise/Conversion

    Class B Common Stock

    2017-02-17+20,00051,250 total
  • Sale

    Class B Common Stock

    2017-02-17$3.71/sh8,965$33,28842,285 total
  • Sale

    Class B Common Stock

    2017-02-21$3.47/sh5,794$20,11336,491 total
  • Exercise/Conversion

    Restricted Stock Units

    2017-02-1631,25093,750 total
    Exercise: $0.00Class B Common Stock (31,250 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2017-02-1720,000220,000 total
    Exercise: $0.00Class B Common Stock (20,000 underlying)
Footnotes (8)
  • [F1]Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
  • [F2]Release and settlement of RSUs granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3.
  • [F3]Represents the aggregate number of shares sold by the Reporting Person on the same day at different prices. All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  • [F4]Represents the weighted average sales price per share. The shares sold at prices ranging from $3.55 to $3.80 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F5]Represents the weighted average sales price per share. The shares sold at prices ranging from $3.45 to $3.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F6]Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
  • [F7]The RSUs vest over 4 years as follows: 25% of the RSUs vested on February 16, 2017 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
  • [F8]The RSUs vest over 5 years as follows: 20% of the RSUs vested on November 17, 2015. Thereafter, the shares vest in 16 quarterly installments each consisting of 5% of the shares subject to the RSU until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting.

Documents

1 file

Issuer

CASTLIGHT HEALTH, INC.

CIK 0001433714

Entity typeoperating

Related Parties

1
  • filerCIK 0001433714

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 8:17 PM ET
Size
16.0 KB